1. |
Adcock IM, Tsaprouni L, Bhavsar P, et al. Epigenetic regulation of airway inflammation. Curr Opin Immunol, 2007 , 19: 694 -700.
|
2. |
田素增, 謝敏, 劉濤, 等. 慢性阻塞性肺疾病大鼠Ⅱ 型肺泡上皮細胞凋亡水平的變化及吸入糖皮質激素對其的影響. 中國呼吸與危重監護雜志, 2007, 6 : 381-384.
|
3. |
Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory disease. Lancet, 2009, 373: 1905-1917.
|
4. |
Dobbs LG, Williams MC. An improved method for isolating typeⅡcells in high yield and purity. Rev Rispir Dis, 1986, 134 : 141-145.
|
5. |
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real -time quantitative PCR and the 2 ( -Delta Delta C( T) ) .Methods, 2001 , 25: 402-408.
|
6. |
張斌, 何威, 楊揚, 等. 體外培養人皮膚鱗狀細胞癌A431 細胞Smad2 和Smad3 mRNA 的表達. 臨床皮膚科雜志, 2008, 37: 290 -292.
|
7. |
Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol, 2000, 20: 6891 -6903.
|
8. |
Ashburner BP, Westerheide SD, Baldwin AS Jr. The p65 ( RelA)subunit of NF- κB interacts with the histone deacetylase ( HDAC)corepressors HDAC1 and HDAC2 to negatively regulate gene expression.Mol Cell Biol, 2001 , 21: 7065-7077.
|
9. |
Ito K, Adcock IM. Histone acetylation and histone deacetylation.Mol Biotechnol, 2002 , 20: 99-106 .
|
10. |
Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J, 2007, 29: 1224-1238.
|
11. |
Szulakowski P, Crowther AJL, Jimenez LA, et al. The effect of smoking on the transcriptional regulation of lung inflammation inpatients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2006, 174: 41-50.
|
12. |
Rajendrasozhan S, Yang SR, Edirisinghe I, et al. Deacetylases and NF-kappaB in redox regulation of cigarette smoke-induced lung inflammation: epigenetics in pathogenesis of COPD. Antioxid Redox Signal, 2008, 10: 799-812 .
|
13. |
Barnes PJ. Role of HDAC2 in the pathophysiology of COPD. Annu Rev Physiol, 2009, 71 : 451-464.
|
14. |
Ito K, Yamamura S, Essilfie-Quaye S, et al. Histone deacetylase 2 -mediated deacetylation of the glucocorticoid receptor enables NFkappaB suppression. J Exp Med, 2006, 203: 7-13.
|